Journal home
Advance online publication
Current issue
Archive
Press releases
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews Immunology
Nature Medicine
Nature Cell Biology
NI Tutorial: Finding regulatory DNA regions
Signaling Gateway
Immunology & Cell Biology
Mucosal Immunology
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Immunology  4, 31 - 37 (2002)
Published online: 2 December 2002; | doi:10.1038/ni870

A small molecule Abl kinase inhibitor induces differentiation of Abelson virus−transformed pre-B cell lines

Stefan A. Muljo1, 2 & Mark S. Schlissel1

1  University of California, Department of Molecular & Cell Biology, Division of Immunology, 439 Life Sciences Addition, Berkeley, CA 94720-3200, USA.

2  Graduate Program in Immunology, The Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.

Correspondence should be addressed to Mark S. Schlissel mss@uclink.berkeley.edu
Abelson murine leukemia virus−transformed cell lines have provided a critical model system for studying the regulation of B cell development. However, transformation by v-Abl blocks B cell development, resulting in the arrest of these transformants in an early pre-B cell−like state. We report here that treatment of Abelson virus−transformed pre-B cell lines with the small molecule Abl kinase inhibitor (STI571) results in their differentiation to a late pre-B cell−like state characterized by induction of immunoglobulin (Ig) light chain gene rearrangement. DNA microarray analyses enabled us to identify two genes inhibited by v-Abl that encode the Igk 3' enhancer−binding transcription factors Spi-B and IRF-4. We show that enforced expression of these two factors is sufficient to induce germline Igk transcription in Abelson-transformed pro-B cell lines. This suggests a key role for these factors, and perhaps for c-Abl itself, in the regulated activation of Ig light chain gene rearrangement.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REVIEWS
Gene segment selection in V(D)J recombination: accessibility and beyond
Nature Immunology Review (01 Jul 2003)
 See all 5 matches for Reviews

NEWS AND VIEWS
Checks and balances on developing B cells
Nature Immunology News and Views (01 Jan 2003)
Inviting leukemic cells to waltz with the devil
Nature Medicine News and Views (01 Feb 2001)
 See all 3 matches for News And Views

RESEARCH
Phosphatidylinositol-3 kinase inhibitors enhance the anti-leukemia effect of STI571
Oncogene Original Paper (29 Aug 2002)
The in vitro activity of the tyrosine kinase inhibitor STI571 in BCR–ABL positive chronic myeloid leukaemia cells: synergistic interactions with anti-leukaemic agents
British Journal of Cancer Molecular And Cellular Pathology (06 May 2002)
 See all 12 matches for Research

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

  • Optimizing Sub-cellular Localization Tags

    • Deadline: Jan 31 2010
    • Reward: $20,000 USD

    The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....

  • Single-cell Analysis Platform

    • Deadline: Dec 02 2009
    • Reward: $5,000 USD

    This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...

naturejobs

Figures & Tables
Supplementary info
See also: News and Views by Kurosaki
See also: Article by Flemming et al.
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Immunology
ISSN: 1529-2908
EISSN: 1529-2916
Journal home | Advance online publication | Current issue | Archive | Press releases | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2003 Nature Publishing Group | Privacy policy